IRIS
GIACOBBE, DANIELE ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.577
AS - Asia 3.253
NA - Nord America 1.420
SA - Sud America 295
AF - Africa 76
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 25.633
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 20.009
US - Stati Uniti d'America 1.352
SG - Singapore 1.331
CN - Cina 808
VN - Vietnam 677
FR - Francia 197
BR - Brasile 171
HK - Hong Kong 115
DE - Germania 88
FI - Finlandia 55
BD - Bangladesh 46
GB - Regno Unito 45
AR - Argentina 40
JP - Giappone 40
NL - Olanda 38
IQ - Iraq 37
IN - India 33
CA - Canada 27
MX - Messico 23
ES - Italia 22
ID - Indonesia 22
EC - Ecuador 19
ZA - Sudafrica 19
PH - Filippine 17
TR - Turchia 16
VE - Venezuela 15
CO - Colombia 14
SE - Svezia 14
JO - Giordania 13
PK - Pakistan 12
RU - Federazione Russa 12
PY - Paraguay 11
UA - Ucraina 11
AU - Australia 9
CL - Cile 9
EG - Egitto 9
NP - Nepal 9
TH - Thailandia 9
UZ - Uzbekistan 9
CH - Svizzera 8
DZ - Algeria 8
MA - Marocco 8
PE - Perù 8
PL - Polonia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
IE - Irlanda 7
KR - Corea 7
AT - Austria 6
ET - Etiopia 6
PT - Portogallo 6
TN - Tunisia 6
UY - Uruguay 6
CR - Costa Rica 5
HU - Ungheria 5
KE - Kenya 5
MY - Malesia 5
RS - Serbia 5
BE - Belgio 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KZ - Kazakistan 4
LB - Libano 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
GA - Gabon 3
GR - Grecia 3
HR - Croazia 3
MK - Macedonia 3
MT - Malta 3
OM - Oman 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
BO - Bolivia 2
IL - Israele 2
KG - Kirghizistan 2
LT - Lituania 2
MD - Moldavia 2
PS - Palestinian Territory 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IR - Iran 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LV - Lettonia 1
MG - Madagascar 1
Totale 25.626
Salva come PNG Salva come JPEG
Città #
Genoa 8.543
Genova 6.926
Vado Ligure 2.159
Rapallo 2.009
Singapore 672
San Jose 438
Ashburn 228
Ho Chi Minh City 211
Lauterbourg 175
Council Bluffs 164
Hanoi 163
Beijing 122
Hong Kong 113
New York 80
Bordighera 78
Frankfurt am Main 63
Helsinki 51
Santa Clara 47
Tokyo 37
Haiphong 34
Rome 32
Los Angeles 28
Milan 26
Da Nang 25
Amsterdam 17
Biên Hòa 17
Orem 17
Chicago 16
São Paulo 15
Baghdad 14
Amman 13
City of London 13
Tianjin 13
Atlanta 12
Guangzhou 12
Madrid 12
Johannesburg 11
Stockholm 11
Toronto 11
London 10
Montreal 10
Paris 10
Hải Dương 9
Quito 9
Tashkent 9
Thái Nguyên 9
Buffalo 8
Can Tho 8
Denver 8
Zurich 8
Asunción 7
Curitiba 7
Istanbul 7
Jakarta 7
Kyiv 7
Lima 7
Mexico City 7
Addis Ababa 6
Bangkok 6
Berlin 6
Chennai 6
Dhaka 6
Marseille 6
Phủ Lý 6
Pozzilli 6
Shanghai 6
Suzhou 6
Warsaw 6
Belgrade 5
Bra 5
Cairo 5
Caracas 5
Dublin 5
Guayaquil 5
Houston 5
Jeddah 5
Mosul 5
Naples 5
Nha Trang 5
Ninh Bình 5
Schiffdorf 5
Shenzhen 5
Sydney 5
Abidjan 4
Bologna 4
Buenos Aires 4
Bắc Ninh 4
Charlotte 4
Dallas 4
Dubai 4
Erbil 4
Florence 4
Fortaleza 4
Hyderabad 4
Islington 4
Izmir 4
Karbala 4
Lappeenranta 4
Lisbon 4
Maceió 4
Totale 22.984
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence and prescription of antibiotic therapy: present and future 409
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 272
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 229
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 228
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 225
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 213
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 213
Mould Infections of Traumatic Wounds: A Brief Narrative Review 211
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 205
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 193
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 191
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 190
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 189
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 187
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 187
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 187
Use of colistin in adult patients: a cross-sectional study 185
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 180
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 179
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 173
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 172
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 171
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 171
Bloodstream infections in critically ill patients with COVID-19 171
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 168
Management of KPC-producing Klebsiella pneumoniae infections 168
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 168
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 167
Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis 166
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 166
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 165
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 164
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 163
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 159
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 159
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 158
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 158
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 155
Will new antimicrobials overcome resistance among Gram-negatives? 154
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 154
Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis 153
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 152
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 152
Treatment of Infections Due to MDR Gram-Negative Bacteria 149
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 148
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 148
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 145
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 145
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 145
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 144
Impact of negative blood cultures on outcome after surgery for acute infective endocarditis 144
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 142
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 141
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 140
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 138
A look at clinical trial design for new antimicrobials for the adult population 137
The role of fosfomycin for multidrug-resistant gram-negative infections 136
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 134
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 133
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 133
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 130
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 129
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 128
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 128
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 127
Culture-negative infective endocarditis (CNIE): impact on postoperative mortality 127
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 127
Bloodstream infections in internal medicine 126
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 126
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 125
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies 124
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 121
Ceftolozane/tazobactam: place in therapy 121
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 121
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 119
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 119
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 119
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 118
A wide database for future studies aimed at improving early recognition of candidemia 117
Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment 115
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 115
Factors associated with lack of viral suppression at delivery 113
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore 112
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 112
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 112
A NLP Pipeline for the Automatic Extraction of a Complete Microorganism’s Picture from Microbiological Notes 111
Ceftobiprole: drug evaluation and place in therapy 111
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 111
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 109
Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis 109
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic 108
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study 108
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 108
Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia 108
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 105
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 104
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 103
Totale 15.347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.142
article - articoli 96.349
book - libri 0
conference - conferenze 1.241
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.235
Totale 197.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021553 0 0 0 0 0 0 0 0 0 220 165 168
2021/20221.858 72 52 93 182 87 134 68 357 223 194 108 288
2022/20232.468 222 207 31 232 294 324 85 161 400 145 303 64
2023/20241.690 80 187 45 216 150 252 142 112 83 77 127 219
2024/20255.696 152 358 157 386 784 580 548 928 240 284 546 733
2025/20269.155 1.262 458 914 727 1.161 637 1.448 666 985 897 0 0
Totale 26.351